We conducted in vitro experiments in healthy donor PBMCs to verify our findings on altered KCNA3, ORAI1, and STIM1 gene expression in dexamethasone-treated COVID-19 patients and confirmed that in vitro treatment with dexamethasone altered the abundance of these ion channel encoding genes. This evidence concerns the gene ORAI1 and COVID-19.